The Health Resources and Services Administration (HRSA) is offering supplemental funding for the Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Network (EGGMIO-RGN) project under the Regional Genetics Networks (RGN) program. The project aims to assess the implementation and outcomes of RGN program activities focused on improving access to genetic and genomic services, especially for underserved populations. Up to three awards will be granted for rigorous evaluations of existing RGN strategies, such as outreach to primary care providers, clinical utility of genetic resources, telehealth services, and dissemination of best practices. The findings will inform the field of genetic and genomic medicine with successful implementation strategies.
Opportunity ID: 333052
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | HRSA-21-110 |
Funding Opportunity Title: | Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Networks (EGGMIO-RGN) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | https://grants.hrsa.gov/2010/Web2External/Interface/FundingCycle/ExternalView.aspx?fCycleID=7d831f34-ff58-41d1-9ec1-37b9481c2a62 |
Expected Number of Awards: | 3 |
Assistance Listings: | 93.110 — Maternal and Child Health Federal Consolidated Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 22, 2021 |
Last Updated Date: | Apr 22, 2021 |
Original Closing Date for Applications: | Jun 07, 2021 |
Current Closing Date for Applications: | Jun 07, 2021 |
Archive Date: | Aug 06, 2021 |
Estimated Total Program Funding: | $495,000 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | Eligible applicants are current recipients who are currently receiving funding under HRSA-20-046 Regional Genetics Network program. |
Additional Information
Agency Name: | Health Resources and Services Administration |
Description: | This notice announces the opportunity to apply for supplemental funding under the Regional Genetics Networks (RGN) program (HRSA-20-046). The purpose of this Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Network (EGGMIO-RGN) project is to evaluate the implementation and outcomes of selected RGN program activities aimed to improve access to services for individuals with, or at risk for, genetic or genomic conditions1 and their families, especially those among underserved populations. This evaluation will be used to inform the RGN recipients and the field of genetic and genomic medicine with best practices and strategies to implement genetic and genomic advances into clinical and public health. HRSA will fund up to three awards, and each RGN recipient will plan and conduct a focused, rigorous evaluation of implementation and/or outcomes of one or more of their program activities to study their utility, applicability, and effectiveness. The evaluation should focus on one or more strategies the RGN is implementing to meet the goals of the RGN program and not a new activity. Example topics of interest include, but are not limited to, evaluating: • Strategies to outreach and engage primary care providers and non-geneticists to provide additional resources, education, or training to improve their ability to use genomics for the care of their patients. • Perceived clinical utility by providers or individuals and families of RGN-developed genetic or genomic resource(s) throughout the lifecycle of diagnosis, treatment, and management. • Implementation and clinical outcomes of RGN-supported genetic or genomic services offered through nontraditional modalities, such as telehealth. • Applicability of RGN developed resources or strategies across regions and subsequent dissemination of lessons learned across the regions. Examples include adaptation of a strategy through multi-RGN collaboration to address unmet needs common across regions or expanding implementation of the strategy to multiple regions. • Impact of integrating the latest scientific evidence relevant to the genetic or genomic condition to improve the utility, applicability and/or effectiveness of the RGN program activity. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Department of Health and Human Services, Health Resources and Services Administration
skim@hrsa.gov Email:skim@hrsa.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 333052 Full Announcement-HRSA-21-110 -> MCHB HRSA-21-110 (UH7) RGN_Final.pdf
Packages
Agency Contact Information: | Department of Health and Human Services, Health Resources and Services Administration skim@hrsa.gov Email: skim@hrsa.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.110 | HRSA-21-110 | Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Networks (EGGMIO-RGN) | PKG00266691 | Apr 22, 2021 | Jun 07, 2021 | View |
Package 1
Mandatory forms
333052 SF424_2_1-2.1.pdf
333052 AttachmentForm_1_2-1.2.pdf
333052 PerformanceSite_2_0-2.0.pdf
333052 ProjectNarrativeAttachments_1_2-1.2.pdf
333052 GG_LobbyingForm-1.1.pdf
333052 BudgetNarrativeAttachments_1_2-1.2.pdf
333052 SF424A-1.0.pdf
Optional forms
333052 SFLLL_1_2-1.2.pdf